Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
RS64400B2Active Publication Date: 2026-05-29VERTEX PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- RS20230581
- Authority / Receiving Office
- RS · RS
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2014-10-03
- Filing Date
- 2015-04-14
- Publication Date
- 2026-05-29
- Estimated Expiration
- 2035-04-14
Need to check novelty before this filing date? Find Prior Art
No text content released.